by The global angiography equipment market size was estimated at around USD 10.08 billion in 2022 and it is projected to hit around USD 17.92 billion by 2032, growing at a CAGR of 5.92% from 2023 to 2032. The angiography equipment market in the United States was accounted for USD 2.9 billion in 2022.
Key Pointers
- North America led the market with a share of 34% in 2022.
- Asia Pacific is expected to emerge as the fastest-growing region with the largest CAGR of 6.28% over the forecast period.
- By Product The angiography systems segment led the market with a share of 27% in 2022.
- By Product Contrast media is expected to be the fastest-growing product segment with a CAGR of 6.35% over the forecast period.
- By Technology The X-ray segment contributed the largest market share of 37% in 2022.
- By Technology MRA is expected to be the fastest-expanding segment with a CAGR of 6.37% over the forecast period.
- By Procedure The coronary angiography segment dominated the market with a share of 46% in 2022.
- By Application The diagnostic application segment dominated the market with the market share of 59% in 2022 and is expected to witness the fastest CAGR of 6.17% between 2023 to 2032.
Get a Sample: https://www.visionresearchreports.com/report/sample/41030
Report Scope of the Angiography Equipment Market
| Report Coverage | Details |
| Market Revenue by 2032 | USD 17.92 billion |
| Growth Rate from 2023 to 2032 | CAGR of 5.92% |
| Revenue Share of North America in 2022 | 34% |
| CAGR of Asia Pacific from 2023 to 2032 | 6.28% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Product Insights
The angiography systems segment led the market with a share of 27% in 2022 due to continuous investments, technological advancements, and growing scope of applications. These systems have evolved from catheter-based minimally invasive procedures to digitalized procedures. In June 2022, MicroPort Scientific Corporation launched the MicroPort Argus optical coherence tomography (OCT) system, featuring OCT as a main endoluminal imaging technology due to its high-resolution feature aiding the customization of treatment for various patients.
The global market is segmented into accessories, systems, guidewires, catheters, balloons, vascular closure devices, and contrast media. Contrast media is expected to be the fastest-growing product segment with a CAGR of 6.35% over the forecast period. These products are widely used for enhancing the visibility of blood vessels in imaging techniques, such as CT angiography, MRA, and X-ray. It is also used in projectional radiography and fluoroscopy. Various radiocontrast agents used are iodine, barium-sulfate, and gadolinium. In November 2022, GE HealthCare announced a USD 80 million investment in expanding its iodinated contrast media production capacity in Norway by 30%, creating 100 new jobs.
Technology Insights
The X-ray segment contributed the largest market share of 37% in 2022. Based on technology, the market is segmented into X-ray, MRA, and CT. Companies are investing heavily in developing new technologies, which is expected to support market growth. The need for reduction of radiation dose, improvement in image quality, and emerging cath lab trends are expected to drive the market. In July 2022, Siemens Healthineers launched Mobilett Impact, a wireless mobile X-ray system, to facilitate scans at the patient’s bedside, increasing the convenience of procedures.
MRA is expected to be the fastest-expanding segment with a CAGR of 6.37% over the forecast period, owing to its advantage of negligible exposure to radiation in the diagnosis of heart disease. MRA offers 3D capabilities to acquire images in any anatomical plane with excellent soft tissue contrast. The emergence of 3.0T MR imaging has significantly enhanced the diagnosis of coronary artery disease. These factors are also said to boost the segment growth.
In June 2022, Siemens Healthineers launched the Artis icono ceiling angiography system, featuring precise tumor embolization and 2D and 3D imaging of tumors. It has multidisciplinary usability and provides seamless integration with third-party software and interfaces.
Procedure Insights
The coronary angiography segment dominated the market with a share of 46% in 2022. The rising prevalence of Coronary Artery Disease (CAD) and the availability of less-invasive imaging modalities are escalating the demand for coronary angiography in developing countries, such as China and India. As per the Centers for Disease Control and Prevention (CDC), CAD is the most common heart disease, killing 375,476 people in 2021. About 5% of adults are diagnosed with CAD, and around 20% of CAD deaths occur in adults aged less than 65 years.
In terms of procedure, the market is segmented into coronary, endovascular, and neurovascular. Constant developments in imaging technology have enabled better diagnosis of the disease. The imaging skill has observed change from single slice CT to multislice CT, providing excellent visualization and assessment of CAD. A wide range of options available for diagnosis include coronary CT angiography, cardiac Magnetic Resonance Imaging (MRI), cardiac Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and integrated SPECT/CT and PET/CT.
Application Insights
The diagnostic application segment dominated the market with the market share of 59% in 2022 and is expected to witness the fastest CAGR of 6.17% during the forecast period. Developments in CTA and MRA provide appropriate information in cardiology and neurology, such as cerebral aneurysms, acute stroke, brain arteriovenous malformation, dural arteriovenous fistula, suspected cerebral vasculitis, and occlusive diseases.
Rising awareness about CVDs and associated risk factors is expected to drive the market. Globally, CAD accounts for the maximum number of deaths and disabilities. The joint initiatives of the WHO and state governments to increase awareness about heart diseases and their underlying causes are further expected to contribute to the angiography equipment market growth.
Regional Insights
North America led the market with a share of 34% in 2022 and is likely to expand further due to the increasing geriatric population and prevalence of CVDs in the region. The presence of major companies in the U.S. is attributed to the major share of the regional market. Europe is also anticipated to witness significant growth over the coming years due to the presence of a majority of local and foreign manufacturers. Growing demand for advanced medical devices and the prevalence of CVD are expected to drive the regional market.
Asia Pacific is expected to emerge as the fastest-growing region with the largest CAGR of 6.28% over the forecast period. Favorable reimbursement policies promoting technological advancements support the region’s growth. The regulatory scenario is not stringent in countries such as South Korea, Brazil, and India, offering an attractive opportunity for global companies to set their footprints in these markets. China is undergoing consolidation to upgrade the quality of this equipment.
Rising imports from the largest market players, such as GE Healthcare, Siemens Healthcare, and Koninklijke Philips N.V., are fueling the growth of the Chinese angiography market. In December 2020, GE Healthcare launched the latest version of its robotic angiography system Allia IGS 7 angiography system for image-guided therapy, operating on a wheeled gantry for better accessibility and transportability.
Key Companies
- Medtronic plc
- Boston Scientific Corporation
- ANGIODYNAMICS
- Abbott
- Microport Scientific Corporation
- B. BRAUN MELSUNGEN AG
- KONINKLIJKE PHILIPS N.V.
- GE Healthcare
- Cardinal Health
- Siemens Healthcare GmbH
- SHIMADZU CORPORATION
Angiography Equipment Market Report Segmentations:
By Product
- Angiography Systems
- Catheters
- Guidewire
- Balloons
- Contrast Media
- Vascular Closure Devices
- Angiography Accessories
By Technology
- X-Ray
- MRA
- CT
By Procedure
- Coronary
- Endovascular
- Neurovascular
By Application
- Diagnostic
- Therapeutic
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41030
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308
